Cleared Traditional

K911145 - BORRELIA BURGDORFERI POLYVAL IGG/IGM AN...

K911145 is the FDA 510(k) clearance for BORRELIA BURGDORFERI POLYVAL IGG/IGM AN... by Medical Diagnostic Technologies, Inc.. It is a Class 2 Microbiology device (product code LSR) cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K911145 · Medical Diagnostic Technologies, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
70d
Days
Class 2
Risk

K911145 is an FDA 510(k) clearance for the BORRELIA BURGDORFERI POLYVAL IGG/IGM ANTIBODY TEST. Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Medical Diagnostic Technologies, Inc. (Augusta, US). The FDA issued a Cleared decision on May 10, 1991 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medical Diagnostic Technologies, Inc. devices

Submission Details

510(k) Number K911145 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 1991
Decision Date May 10, 1991
Days to Decision 70 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 102d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 58
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K911145.
LYME IGM ELISA TEST
K903013 · Gull Laboratories, Inc. · Jun 1991
LYME DISEASE MICROASSAY
K910899 · Diamedix Corp. · Jun 1991
LYME IGM MICROASSAY
K911330 · Diamedix Corp. · Jun 1991
3M IGG FASTLYME(TM) TEST
K895713 · 3M Company · Dec 1990
LYME IGM ELISA TEST SYSTEM
K900196 · Zeus Scientific, Inc. · May 1990
LYME IGM MICROASSAY
K900572 · Diamedix Corp. · May 1990